Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080312 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02080312 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 6 participants.
The verdict
NCT02080312, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a pilot study of patients with clinical symptoms of Ménière's disease using injection of diluted magnetic resonance imaging (MRI) contrast agent into the ear to evaluate inner ear structures. The goal is to reproduce imaging findings described by non-United States (US) institutions, improve on image quality with decreased scan time and evaluate the dynamics of the contrast movement into the inner ear structures.
Interventions
- DRUG Magnevist (gadopentetate dimeglumine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02080312
The ClinicalTrials.gov registry entry for NCT02080312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnevist (gadopentetate dimeglumine) is the first listed.
NCT02080312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02080312 about?
NCT02080312 is a clinical study titled "Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent". This is a pilot study of patients with clinical symptoms of Ménière's disease using injection of diluted magnetic resonance imaging (MRI) contrast agent into the ear to evaluate inner ear structures. The goal is to reproduce imaging findings described by non-United States (US) institutions, improve...
What is the current status of trial NCT02080312?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2012-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02080312?
The interventions under investigation include: Magnevist (gadopentetate dimeglumine) (DRUG).
Who is sponsoring clinical trial NCT02080312?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.